OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
6822$0.4055

6822.HK

Commodity ChemicalsVerified

The company's capital structure is characterized by a market cap of 276.5 million HKD and a price-to-book ratio of 0.65, indicating that the market values the company at a discount to its book value. The debt-to-equity ratio of 0.25 suggests a relatively conservative leverage position, with long-term debt amounting to 104.085 million HKD against total equity of 424.576 million HKD. The current ratio of 2.57 indicates strong short-term liquidity, with current assets significantly outpacing current liabilities. Profitability metrics reveal a challenging operating environment. The company reported a net loss of 108.913 million HKD and an operating loss of 99.802 million HKD, resulting in a negative return on equity of -25.65% and a negative return on assets of -17.6%. These figures fall well below the typical performance of the Commodity Chemicals industry, which is known for its cyclical nature and sensitivity to raw material costs and demand fluctuations. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns and regulatory changes. The absence of segment-specific data limits the ability to assess the performance of individual product lines or geographic regions. The company's growth trajectory is currently negative, with a reported revenue of 464.602 million HKD. The outlook for the current fiscal year is uncertain, with no disclosed revenue growth projections. The company's operating losses and negative returns suggest a need for strategic cost management or revenue diversification to improve financial performance. Risk factors include liquidity concerns, as the company has negative net cash after subtracting total debt. The risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate pressure for equity issuance. The company's financial position is further complicated by its operating losses, which may necessitate additional financing or operational restructuring. Recent events include the latest financial filing, which discloses the company's operating losses and negative returns. No recent earnings call transcripts or significant corporate actions have been reported, limiting the visibility into management's strategic direction and operational adjustments.

30-day price · 6822-0.01 (-2.5%)
Low$0.37High$0.41Close$0.40As of21 May, 00:00 UTC
Profile
Company6822.HK
Ticker6822.HK
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and consumer markets.

Classification. The company is classified under the industry of Commodity Chemicals within the Basic Materials economic sector, with a confidence level of 0.92.

The company's capital structure is characterized by a market cap of 276.5 million HKD and a price-to-book ratio of 0.65, indicating that the market values the company at a discount to its book value. The debt-to-equity ratio of 0.25 suggests a relatively conservative leverage position, with long-term debt amounting to 104.085 million HKD against total equity of 424.576 million HKD. The current ratio of 2.57 indicates strong short-term liquidity, with current assets significantly outpacing current liabilities. Profitability metrics reveal a challenging operating environment. The company reported a net loss of 108.913 million HKD and an operating loss of 99.802 million HKD, resulting in a negative return on equity of -25.65% and a negative return on assets of -17.6%. These figures fall well below the typical performance of the Commodity Chemicals industry, which is known for its cyclical nature and sensitivity to raw material costs and demand fluctuations. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns and regulatory changes. The absence of segment-specific data limits the ability to assess the performance of individual product lines or geographic regions. The company's growth trajectory is currently negative, with a reported revenue of 464.602 million HKD. The outlook for the current fiscal year is uncertain, with no disclosed revenue growth projections. The company's operating losses and negative returns suggest a need for strategic cost management or revenue diversification to improve financial performance. Risk factors include liquidity concerns, as the company has negative net cash after subtracting total debt. The risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate pressure for equity issuance. The company's financial position is further complicated by its operating losses, which may necessitate additional financing or operational restructuring. Recent events include the latest financial filing, which discloses the company's operating losses and negative returns. No recent earnings call transcripts or significant corporate actions have been reported, limiting the visibility into management's strategic direction and operational adjustments.
Key takeaways
  • The company is operating at a net loss with a negative return on equity, indicating poor profitability.
  • The company's capital structure is relatively conservative, with a low debt-to-equity ratio and strong short-term liquidity.
  • The company lacks geographic and segment diversification, increasing its exposure to regional and product-specific risks.
  • The company's growth trajectory is currently negative, with no disclosed revenue growth projections for the current fiscal year.
  • The company faces liquidity risks due to negative net cash after subtracting total debt.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyHKD
Revenue$464.6M
Gross profit$82.9M
Operating income-$99.8M
Net income-$108.9M
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets$619.0M
Total liabilities$194.4M
Total equity$424.6M
Cash & equivalents
Long-term debt$104.1M
Valuation
Market price$0.40
Market cap$276.5M
Enterprise value$380.6M
P/E
Reported non-GAAP P/E
EV/Revenue0.8
EV/Op income
EV/OCF
P/B0.7
P/Tangible book0.7
Tangible book$424.6M
Net cash-$104.1M
Current ratio2.6
Debt/Equity0.2
ROA-17.6%
ROE-25.7%
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
Metric6822Activity
Op margin-21.5%5.5% medp25 -0.0% · p75 10.8%bottom quartile
Net margin-23.4%4.1% medp25 0.1% · p75 8.8%bottom quartile
Gross margin17.9%20.5% medp25 12.4% · p75 29.7%below median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-6.2% medp25 -13.4% · p75 -2.6%
Debt / equity25.0%37.1% medp25 10.3% · p75 82.0%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 21:53 UTC#b8eb5e58
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 02:17 UTCJob: c174feb1